Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Thyrotoxic atrial fibrillation.

Malvinder S Parmar¹

¹Northern Ontario School of Medicine, Laurentian University, Sudbury, Canada.

Medgenmed : Medscape General Medicine

|December 22, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review.

Canadian journal of kidney health and disease·2026

Same author

Nihilism versus masterly inactivity in medicine: Reclaiming therapeutic restraint.

The American journal of medicine·2026

Same author

Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial.

Canadian journal of kidney health and disease·2025

Same author

Gastroesophageal Reflux Disease.

The New England journal of medicine·2023

Same author

Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review.

Canadian journal of kidney health and disease·2023

Same author

Removal of Small, Asymptomatic Kidney Stones and Relapse.

The New England journal of medicine·2022

Same journal

Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".

MedGenMed : Medscape general medicine·2008

Same journal

Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".

MedGenMed : Medscape general medicine·2008

Same journal

Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".

MedGenMed : Medscape general medicine·2008

Same journal

Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".

MedGenMed : Medscape general medicine·2008

Same journal

Readers' and author's responses to "We all need healthcare; who needs 'insurance'?".

MedGenMed : Medscape general medicine·2008

Same journal

Readers' and author's responses to "The disappearing patient".

MedGenMed : Medscape general medicine·2008

See all related articles

Hyperthyroidism frequently causes atrial fibrillation, increasing stroke risk. Managing this requires adjusting medications like anticoagulants and rate-controlling agents due to altered drug metabolism.

Area of Science:

Cardiology
Endocrinology
Pharmacology

Background:

Atrial fibrillation is a common cardiac complication in hyperthyroidism, affecting up to 15% of patients.
Hyperthyroidism significantly increases the risk of thromboembolism, particularly affecting the central nervous system.

Observation:

Patients with thyrotoxic atrial fibrillation often require oral anticoagulation to prevent thromboembolic events.
Hyperthyroidism alters drug metabolism, necessitating dose adjustments for rate-controlling agents due to increased clearance.
Warfarin dosage requires reduction in these patients because hyperthyroidism accelerates the clearance of vitamin K-dependent clotting factors.

Findings:

Thyrotoxicosis-induced atrial fibrillation presents unique management challenges.

Related Experiment Videos

Pharmacokinetic changes in hyperthyroidism impact the efficacy and safety of commonly used medications.

Implications:

Optimizing anticoagulation and rate control is crucial for managing thyrotoxic atrial fibrillation.
This review provides a summary of clinical management strategies for this patient population.
Understanding drug interactions and metabolic changes is key to effective treatment.